| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.5M | -63.5% |
| Cost of Revenue | $343K | -83.3% |
| R&D Expense | $19.6M | +93.0% |
| SG&A Expense | $15.3M | +76.3% |
| Operating Income | -$42.5M | -649.9% |
| Interest Expense | $335K | +48.2% |
| Pre-tax Income | -$42.3M | -396.8% |
| Income Tax | -$786K | -2411.8% |
| Net Income | -$41.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.5M | -41.7% |
| Accounts Receivable | $7.2M | +405.6% |
| Current Assets | $93.0M | -19.1% |
| Total Assets | $115.5M | -13.1% |
| Current Liabilities | $11.7M | +177.2% |
| Total Liabilities | $29.7M | +410.4% |
| Stockholders' Equity | $85.8M | -32.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.7M | -279.3% |
| Capital Expenditures | $93K | -8.8% |
| Investing Cash Flow | -$36.7M | -136.5% |
| Financing Cash Flow | $8.4M | -92.6% |
| Free Cash Flow | -$18.8M | -282.0% |
| -385.6% |
| EPS (Basic) | -$1.20 | +43.1% |